Come up with a name for your new list and we'll add to it:
Auspherix raised a round of funding on October 23, 2014. Investors include
Medical Research Commercialisation Fund.
Auspherix has discovered a brand new class of antibacterials with a unique profile and novel mechanism of action that could overcome rising problems of resistance to current antibiotics. Its compound …